ArticleExperimental and therapeutic medicine2025
Sclerosing angiomatoid nodular transformation mimicking a splenic metastasis from rectal cancer: A case report.
Article in Experimental and therapeutic medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Imaging and pathological features of pediatric sclerosing angiomatoid nodular transformation of the spleen: a case series and hypothesis-generating perspective on non-operative management.Translational pediatrics · 2026Article
- Case Report: Sclerosing angiomatoid nodular transformation of the spleen: surgery or conservative treatment?Frontiers in immunology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sclerosing angiomatoid nodular transformation (SANT) is a rare, benign lesion of the spleen. Preoperative diagnosis of SANT without pathological examination poses significant challenges, particularly in patients with a previous history of malignancy. The present study describes the case of a 53-year-old woman that presented to our institution with general fatigue and anemia. Based on a diagnosis of rectal cancer, the patient underwent curative surgery. Postoperatively, with minor leakage and the need for endoluminal drainage, the patient was monitored without adjuvant chemotherapy. A total of 1 year post-operation, enhanced computed tomography (CT) revealed a low-density lesion measuring 7 mm in the spleen. While metachronous metastasis was considered, there was no accumulation of 18F-fluorodeoxyglucose, and the levels of tumor markers, such as carcinoembryonic antigen and carbohydrate antigen 19-9, remained unremarkable. Regular surveillance through contrast-enhanced CT was performed. Over a period of 3 years, the tumor gradually increased to 25 mm. After a diagnosis of metachronous metastasis from rectal cancer, the patient opted for surgery, and laparoscopic splenectomy was performed successfully. Histopathological examination of multiple angiomatoid nodules in the fibrosclerotic stroma confirmed the diagnosis of SANT. The postoperative course of the patient was uneventful. In cases of SANT following a prior malignancy, splenectomy should be considered for both diagnostic and therapeutic purposes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.